# TRIAMTERENE AND HYDROCHLOROTHIAZIDE
> **ANDA073449** · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS · Approved 1993-09-23
## Drug
- **FDA Application Number:** ANDA073449
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- **Generic name:** TRIAMTERENE AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; TRIAMTERENE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** WATSON LABS
- **Manufacturer:** BluePoint Laboratories
- **First approval:** 1993-09-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=073449)
---
*AI Analytics · CC0 1.0*